April 30, 2021 — A former class action regarding Avodart has been discontinued and abandoned against the drug manufacturer (GlaxoSmithKline) regarding allegations that using Avodart can cause high grade prostate cancer, and permanent or temporary sexual dysfunction. These allegations were not proven in Court. The Avodart class action has been fully discontinued.
However, GlaxoSmithKline has agreed to settle (on an individual basis) certain qualifying legal claims made by Canadian residents who (1) have used Avodart and (2) were subsequently diagnosed with high grade prostate cancer.
The same individual compensation process is currently underway and the deadline to apply for individual compensation is July 28, 2021. No individual claims can be submitted after July 28, 2021. If you have been diagnosed with high grade prostate cancer and previously used Avodart, please contact our law firm ASAP.
For more information, you should immediately email our law firm at: Avodart@merchantlaw.com with details regarding your high grade prostate cancer and Avodart usage. Please also provide your full contact information. [You may also call our law office for a free initial consultation without obligation, at 306-653-7756, regarding Avodart compensation claims from anywhere in Canada.]
Please take note of the following court-approved documentation [in PDF below] regarding this settlement: